NEU 2.71% $19.70 neuren pharmaceuticals limited

My simple valuation for Neuren is based on the share price that...

  1. 2,537 Posts.
    lightbulb Created with Sketch. 374
    My simple valuation for Neuren is based on the share price that was achieved prior to 2591 phase 2 readout and a basic allowance for the success of each of the 4 x 2591 indications.

    So say 2 billion for Daybue, then add 60% of 2 billion fir indication 1 and 20% of 2 billion fir the other 3.

    Gives a 3.6 billion value right now.

    If the other indications prove up in phase 2 the increase them to 60% which gets 6.8 billion.

    Basic I know but that’s what I’m thinking now.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.70
Change
0.520(2.71%)
Mkt cap ! $2.515B
Open High Low Value Volume
$19.39 $19.84 $19.28 $5.675M 288.6K

Buyers (Bids)

No. Vol. Price($)
3 1531 $19.66
 

Sellers (Offers)

Price($) Vol. No.
$19.81 557 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$19.70
  Change
0.520 ( 2.59 %)
Open High Low Volume
$19.50 $19.84 $19.28 87628
Last updated 15.59pm 03/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.